1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Pancreatic Adenocarcinoma : Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
- Contribution to journal › Article
- 2024
-
Mark
Genome plasticity shapes the ecology and evolution of Phocaeicola dorei and Phocaeicola vulgatus
- Contribution to journal › Article
- 2023
-
Mark
Longitudinal observational study protocol - Preterm Infants : Microbiome Establishment, Neuro-CrossTalk and Origins (PIMENTO)
- Contribution to journal › Article
- 2017
-
Mark
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4) : A multicentre, open-label, randomised, phase 3 trial
- Contribution to journal › Article
